MagicMed Industries to Webcast Live at Life Sciences Investor Forum on March 25th
MagicMed Industries is set to present its business and pipeline updates at the Life Sciences Investor Forum on March 25, 2021, at 10:00 AM EST. The event encourages real-time interaction, allowing participants to ask questions. For those unable to attend live, an archived webcast will be available post-event. MagicMed is focused on developing psychedelic derivative molecules, particularly from its Psybrary library, which includes psilocybin and DMT derivatives. Investors are urged to pre-register for updates.
- None.
- None.
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com
CALGARY, Alberta, March 22, 2021 (GLOBE NEWSWIRE) -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused on creating novel psychedelic derivative molecules, today announced that Dr. Joseph Tucker, President and Chief Executive Officer, will be presenting a business and pipeline update at the LifeSciencesInvestorForum.com on March 25th, 2021 as follows:
DATE: Thursday, March 25, 2021
TIME: 10:00AM EST
LINK: https://bit.ly/3qVRFyI
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, and archived webcast will also me made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.lifesciencesinvestorforum.com.
About MagicMed
MagicMed Industries intends to partner with pharmaceutical and other companies to develop and commercialize psychedelic-derived pharmaceutical candidates. MagicMed's psychedelic derivatives library, the PsybraryTM, is intended to be an essential building block from which the industry can develop new patented products. The initial focus of the PsybraryTM is on psilocybin and DMT derivatives, and the PsybraryTM is then expected to be expanded to other psychedelics such as MDMA, LSD, mescaline, and ibogaine.
About Life Sciences Investor Forum
Life Sciences Investor Forum is a proprietary investor conference series that provides an interactive forum for life sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results and future events could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. All statements other than statements of present or historical fact are forward-looking statements, including, without limitation, statements with respect to MagicMed's future business plans and partnerships, the anticipated uses of the PsybraryTM and the Company’s plans for the development of the PsybraryTM. Forward-looking statements include words or expressions such as "proposed", "anticipated", "will", "subject to", "near future", "in the event", "would", "expect", "prepared to" and other similar words or expressions.
Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. Some of the risks and other factors could cause results to differ materially from those expressed in the forward-looking statements which include, but are not limited to: the ability of MagicMed to secure patent protection; the regulatory environment in which MagicMed operates; the ability of MagicMed to enter into partnership agreements or other arrangements; the ability of MagicMed to carry out its business plans (including but not limited to its plans to file a prospectus and apply to list on a stock exchange); unforeseen challenges in carrying out such plans; the development and expansion of the PsybraryTM; trends in the future use of psilocybin; general business, economic, competitive, political and social uncertainties; the state of capital markets; risks relating to general economic, market and business conditions; and other unforeseen events, developments, or factors causing any of the aforesaid expectations, assumptions, and other factors ultimately being inaccurate or irrelevant. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We disclaim any obligation to update or revise these forward-looking statements, except as required by applicable law.
FAQ
What is the date and time of MagicMed's presentation at the Life Sciences Investor Forum?
How can I join MagicMed's presentation at the Life Sciences Investor Forum?
Will there be a recording of MagicMed's presentation available?
What is the focus of MagicMed Industries?
What type of investors are invited to the Life Sciences Investor Forum event?
